Trials / Conditions / Pemphigoid, Bullous
Pemphigoid, Bullous
7 registered clinical trials studyying Pemphigoid, Bullous.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP) NCT06148090 | University Hospital, Bordeaux | N/A |
| Unknown | The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid NCT04465292 | Brigham and Women's Hospital | EARLY_Phase 1 |
| Terminated | A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid NCT04499235 | Alkahest, Inc. | Phase 2 |
| Completed | Cytokines in Blister Fluids of Bullous Pemphigoid (BP) NCT03856840 | Mahmut Can Koska | — |
| Completed | Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid NCT02226146 | Alexion Pharmaceuticals, Inc. | Phase 2 |
| Terminated | Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid NCT01559155 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Anti-IL-5 Therapy in Bullous Pemphigoid (BP) NCT01705795 | Insel Gruppe AG, University Hospital Bern | Phase 2 |